Seres Therapeutics (Germany) Buy Hold or Sell Recommendation
| 1S9 Stock | EUR 0.83 0.05 5.68% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Seres Therapeutics is 'Strong Sell'. Macroaxis provides Seres Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 1S9 positions.
Check out Seres Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Seres Stock please use our How to Invest in Seres Therapeutics guide. Note, we conduct extensive research on individual companies such as Seres and provide practical buy, sell, or hold advice based on investors' constraints. Seres Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Seres |
Execute Seres Therapeutics Buy or Sell Advice
The Seres recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Seres Therapeutics. Macroaxis does not own or have any residual interests in Seres Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Seres Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Seres Therapeutics Trading Alerts and Improvement Suggestions
| Seres Therapeutics had very high historical volatility over the last 90 days | |
| Seres Therapeutics has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 144.93 M. Net Loss for the year was (65.58 M) with profit before overhead, payroll, taxes, and interest of 3.04 M. | |
| Over 86.0% of the company shares are owned by institutions such as pension funds |
Seres Therapeutics Returns Distribution Density
The distribution of Seres Therapeutics' historical returns is an attempt to chart the uncertainty of Seres Therapeutics' future price movements. The chart of the probability distribution of Seres Therapeutics daily returns describes the distribution of returns around its average expected value. We use Seres Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Seres Therapeutics returns is essential to provide solid investment advice for Seres Therapeutics.
| Mean Return | 0.32 | Value At Risk | -12.5 | Potential Upside | 10.61 | Standard Deviation | 8.02 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Seres Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Seres Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Seres Therapeutics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Seres Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Seres stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.23 | |
β | Beta against Dow Jones | 0.72 | |
σ | Overall volatility | 7.93 | |
Ir | Information ratio | 0.02 |
Seres Therapeutics Volatility Alert
Seres Therapeutics is displaying above-average volatility over the selected time horizon. Seres Therapeutics is a potential penny stock. Although Seres Therapeutics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Seres Therapeutics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Seres instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Seres Therapeutics Fundamentals Vs Peers
Comparing Seres Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Seres Therapeutics' direct or indirect competition across all of the common fundamentals between Seres Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Seres Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Seres Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Seres Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Seres Therapeutics to competition |
| Fundamentals | Seres Therapeutics | Peer Average |
| Return On Equity | -1.9 | -0.31 |
| Return On Asset | -0.4 | -0.14 |
| Operating Margin | (17.02) % | (5.51) % |
| Current Valuation | 582.79 M | 16.62 B |
| Shares Outstanding | 124.59 M | 571.82 M |
| Shares Owned By Insiders | 6.66 % | 10.09 % |
| Shares Owned By Institutions | 85.90 % | 39.21 % |
| Price To Book | 12.02 X | 9.51 X |
| Price To Sales | 50.23 X | 11.42 X |
| Revenue | 144.93 M | 9.43 B |
| Gross Profit | 3.04 M | 27.38 B |
| EBITDA | (56.72 M) | 3.9 B |
| Net Income | (65.58 M) | 570.98 M |
| Cash And Equivalents | 253.62 M | 2.7 B |
| Cash Per Share | 2.77 X | 5.01 X |
| Total Debt | 24.64 M | 5.32 B |
| Debt To Equity | 0.23 % | 48.70 % |
| Current Ratio | 5.79 X | 2.16 X |
| Book Value Per Share | 0.54 X | 1.93 K |
| Cash Flow From Operations | 6.69 M | 971.22 M |
| Earnings Per Share | (2.18) X | 3.12 X |
| Target Price | 20.57 | |
| Number Of Employees | 333 | 18.84 K |
| Beta | 2.68 | -0.15 |
| Market Capitalization | 608.32 M | 19.03 B |
| Total Asset | 354.86 M | 29.47 B |
| Z Score | 14.4 | 8.72 |
| Net Asset | 354.86 M |
Seres Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Seres . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Seres Therapeutics Buy or Sell Advice
When is the right time to buy or sell Seres Therapeutics? Buying financial instruments such as Seres Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Seres Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Penny Thematic Idea Now
Penny
Solid stocks, funds or ETFs with below average market capitalization and typicl daily price below 2. The Penny theme has 56 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Penny Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Information and Resources on Investing in Seres Stock
When determining whether Seres Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Seres Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Seres Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Seres Therapeutics Stock:Check out Seres Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Seres Stock please use our How to Invest in Seres Therapeutics guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.